FDA Approves Dupilumab (Dupixent) for Treatment of COPD
HCPLive
SEPTEMBER 27, 2024
This approval by the FDA follows positive findings from the pivotal BOREAS and NOTUS trials on adults with uncontrolled COPD.
Fri.Sep 27, 2024
124 
Babies born after fertility treatment have higher risk of heart defects, study suggests
Science Daily - Heart Disease
SEPTEMBER 27, 2024
The risk of being born with a major heart defect is 36% higher in babies who were conceived after assisted reproductive technology, such as in vitro fertilization (IVF), according to results of a very large study.
Evidence of a bi-directional relationship between heart failure and diabetes: a strategy for the detection of glucose abnormalities and diabetes prevention in patients with heart failure
Cardiovascular Diabetology
SEPTEMBER 27, 2024
Prevalence of heart failure (HF) and diabetes are markedly increasing globally. In a population of HF patients, approximately 40% have diabetes which is associated with a more severe HF, poorer cardiovascular.
Is Ultra-Processed Food Really That Bad For You?
Dr. Paddy Barrett
SEPTEMBER 27, 2024
Ultra-processed foods are a modern invention. They are here to stay. But are ultra-processed foods really that bad for you? The answer is yes. Kind of. Let Me Explain. There is a huge body of evidence that points to the harms of ultra-processed foods on health outcomes. For every serving of ultra-processed food, the risk of an early death increases by 18% 1.
Biosimilars Saved $12.3 Billion in 2023, a Fraction of Potential Savings
HCPLive
SEPTEMBER 27, 2024
To date, biosimilars have supported 495 million incremental days of therapy that patients would otherwise not have received.
How to Tell When Imaging Equipment Has Reached End-of-Life (and How to Extend Its Value)
Cassling
SEPTEMBER 27, 2024
Like humans, medical imaging equipment shows signs of aging. But instead of creaky joints, wrinkles, or gray hair, the machinery gives other hints that it is wearing out and that it might be time for you to make a change. Here are five signs that your imaging equipment is approaching its last lap, plus tips on what you can do to get a little more usage out of it before it completely gives out.
Promising Emergent Therapies for Lowering Lp(a) with Michelle O’Donoghue
HCPLive
SEPTEMBER 27, 2024
In an interview O’Donoghue talked about emerging RNA therapies for Lp(a) in phase 2 and 3 trials.
Sign up to get articles personalized to your interests!
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
More Trending
Tralokinumab Reduced Severity of Atopic Dermatitis in Head, Neck Regions After 9 Months
HCPLive
SEPTEMBER 27, 2024
The 9-month interim results of the TRACE study were presented at EADV 2024, highlighting tralokinumab’s efficacy in a subset of patients with eczema impacting the head and neck areas.
Is Fasting Before Catheterization Procedures Really Safer?
NEJM Journal Watch - Cardiology
SEPTEMBER 27, 2024
A no-fasting approach prior to elective cath lab procedures resulted in fewer safety events and improved patient satisfaction.
Harpreet Bhatia, MD: Benefits of Universal Screening for Lp(a) Levels
HCPLive
SEPTEMBER 27, 2024
At the Family Heart Global Summit 2024, Bhatia spoke about the importance of universal Lp(a) screening over only targeted screening.
Cancer’s CVD Risks and SGLT2is’ Preventative Potential
CardiacWire
SEPTEMBER 27, 2024
Better treatments have led to improved cancer survival rates, but new research reveals increased cardiovascular complications in survivors. However, another new study offers hope, suggesting that heart medications like SGLT2 inhibitors may help prevent cancer-related heart disease. A new Cancer Journal study showed that older cancer survivors have far higher rates of cardiovascular events than their peers who never had cancer.
Iron Deficiency Extremely Common by Third Trimester of Pregnancy
HCPLive
SEPTEMBER 27, 2024
A large study shows no women were anemic in the first trimester of pregnancy, but more than 80% of the women were iron deficient by the third trimester.
Myocardial Fibrosis and Outcomes in Aortic Stenosis
American College of Cardiology
SEPTEMBER 27, 2024
How does diffuse interstitial myocardial fibrosis, as observed on cardiac magnetic resonance (CMR), correlate with clinical outcomes in moderate and asymptomatic severe aortic stenosis (AS)?
Advances in Non-Statin Therapies for Dyslipidemia, with Christie Ballantyne, MD
HCPLive
SEPTEMBER 27, 2024
Christie Ballantyne, MD, discusses non-statin therapies, both approved and in development, for managing dyslipidemias from the floor of the 2024 Family Heart Global Summit.
Association of semaglutide treatment with coronary artery inflammation in type 2 diabetes mellitus patients: a retrospective study based on pericoronary adipose tissue attenuation
Cardiovascular Diabetology
SEPTEMBER 27, 2024
The pericoronary fat attenuation index (FAI) has emerged as a novel and sensitive biomarker reflecting the degree of coronary artery inflammation. Semaglutide has been demonstrated to exert a cardiovascular pr.
The APAC Recap: AHA Hypertension Scientific Sessions 2024
HCPLive
SEPTEMBER 27, 2024
In this episode, John Giacona, PhD, PA-C, shares insights from the 2024 AHA Hypertension Scientific Sessions, focusing on primary aldosteronism and renal denervation.
Construction of machine learning diagnostic models for cardiovascular pan-disease based on blood routine and biochemical detection data
Cardiovascular Diabetology
SEPTEMBER 27, 2024
Cardiovascular disease, also known as circulation system disease, remains the leading cause of morbidity and mortality worldwide. Traditional methods for diagnosing cardiovascular disease are often expensive a.
Barzolvolimab Leads to Rapid, Sustained Improvements in CSU Over 52 Weeks
HCPLive
SEPTEMBER 27, 2024
These new data were announced by Celldex Therapeutics regarding the sustained and deepening efficacy of barzolvolimab treatment of chronic spontaneous urticaria.
Impact of baseline FIB-4 score on efpeglenatide benefits on cardiovascular outcomes in people with type 2 diabetes: a participant-level exploratory analysis of the AMPLITUDE-O trial
Cardiovascular Diabetology
SEPTEMBER 27, 2024
To estimate the incidence of major adverse cardiovascular events (MACE), expanded MACE, and MACE or Death across Fibrosis- 4 score (FIB-4) categories in people with type 2 diabetes and to determine whether efp.
Healthcare Provider-Led Education Among Most Effective Strategies for HBV Testing
HCPLive
SEPTEMBER 27, 2024
HBV education led by healthcare providers, decentralized testing, and strategies with more framework-driven mechanisms had the greatest impact on testing uptake.
Effects of adipose tissues on the relationship between type 2 diabetes mellitus and reduced heart rate variability: mediation analysis
Cardiovascular Diabetology
SEPTEMBER 27, 2024
Type 2 diabetes mellitus (T2DM) is associated with decreased heart rate variability (HRV) with an unclear intermediate mechanism. This study aimed to conduct mediation analysis to explore the impact of various.
Jessica Crimaldi, NP: Diagnosing, Treating Abdominal Pain in GI Inpatients
HCPLive
SEPTEMBER 27, 2024
Crimaldi reviews key considerations for the diagnosis and management of bowel ischemia, diverticulitis, and small bowel obstructions in GI inpatients.
Former NFL QB's Dementia; Stem Cells Reverse Woman's Diabetes; More Free COVID Tests
Med Page Today
SEPTEMBER 27, 2024
(MedPage Today) -- Note that some links may require registration or subscription. Former Minnesota Vikings quarterback Tommy Kramer revealed his dementia diagnosis. (AP via ESPN) Florida hospitals are postponing elective procedures and preparing.
Why Interoperability is Key to Personalized Treatment Plans in Cardiology
GEMMS
SEPTEMBER 27, 2024
Personalized treatment in cardiology has become a cornerstone of modern healthcare, allowing doctors to tailor interventions to each patient’s unique needs. Cardiovascular diseases vary widely, so personalized care is critical for improving outcomes and patient satisfaction. One key enabler of such customized treatment is interoperability, which empowers healthcare providers by connecting healthcare systems and ensuring that all relevant patient information is available for informed decisi
Hsa_circ_0079929 in lung adenocarcinoma and its biological implications in lung adenocarcinoma progression
Journal of Cardiothoracic Surgery
SEPTEMBER 27, 2024
This report investigated the expression, prognostic and biological implications of hsa_circ_0079929 in lung adenocarcinoma, which was based on clinical and experimental data.
FDA Approves Flurpiridaz F 18 Diagnostic Drug for Coronary Artery Disease
HCPLive
SEPTEMBER 27, 2024
The approval to GE Healthcare's cyclotron-produced radioactive diagnostic drug provides another option to adequately identify significant coronary artery disease.
VT Substrates in Children and Young Adults With Repaired TOF
American College of Cardiology
SEPTEMBER 27, 2024
What substrates exist for ventricular tachycardia (VT) in patients with repaired tetralogy of Fallot (TOF) <30 years of age?
NLA Expert Consensus Examines Role of ApoB in ASCVD Risk Assessment
HCPLive
SEPTEMBER 27, 2024
Expert clinical consensus from the National Lipid Association finds ApoB testing is useful to stratify ASCVD risk more accurately than LDL-C.
Systematic Review on Diet and Risk of AF: Key Points
American College of Cardiology
SEPTEMBER 27, 2024
The following are key points to remember from a systematic review on diet and risk of atrial fibrillation (AF).
Primary intracardiac leiomyoma: rare case report and literature review
Journal of Cardiothoracic Surgery
SEPTEMBER 27, 2024
Benign cardiac neoplasms are relatively uncommon. Cardiac leiomyomas are usually diagnosed as a benign metastasizing leiomyoma or as a part of intravenous leiomyomatosis spectrum. Primary cardiac leiomyomas ar.
"Under"-reporting of complications following AF ablation: Comparison of the Manufacturer and User Facility Device Experience FDA database and a voluntary invitation-based registry - the POTTER-AF 3 Study
HeartRhythm
SEPTEMBER 27, 2024
The Manufacturer and User Facility Device Experience (MAUDE) database houses medical device reports of adverse events involving medical devices marketed in the United States submitted to the U.S. Food and Drug Administration (FDA) by mandatory and voluntary reporters. The MAUDE database is frequently used in clinical studies to report on device-related complications.
Considering Viral Infections in Patients With Rheumatic Disease With Leonard Calabrese, DO
HCPLive
SEPTEMBER 27, 2024
Calabrese discussed factors for rheumatologists to keep in mind, including recent travel and screening for viral infections.
Let's personalize your content